BrainAurora Medical Technology Limited (HKG:6681)
Hong Kong · Delayed Price · Currency is HKD 1.085
-0.060 (-5.24%)
Oct 2, 2026, 4:08 PM HKT
HKG:6681 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 239.88 | 220.05 | 122.31 | 67.2 | 11.29 | 2.3 | |
Revenue Growth | 40.71% | 79.91% | 82.01% | 495.16% | 391.13% | - |
Cost of Revenue | 136.66 | 130.6 | 68.3 | 35.14 | 7.99 | 1 |
Gross Profit | 103.22 | 89.45 | 54.01 | 32.06 | 3.3 | 1.3 |
Selling, General & Admin | 188.51 | 175.58 | 107.94 | 87.27 | 39.69 | 37.6 |
Research & Development | 161.2 | 165.9 | 119.42 | 90.73 | 67.63 | 32.76 |
Operating Expenses | 384.22 | 380.41 | 238.85 | 178.85 | 107.37 | 70.37 |
Operating Income | -281.01 | -290.95 | -184.83 | -146.78 | -104.07 | -69.06 |
Interest Expense | -22.92 | -23.99 | -22.03 | -20.22 | -19.22 | -6.39 |
Interest & Investment Income | 15.66 | 13.65 | 0.63 | 2.08 | 3.9 | 1.33 |
Currency Exchange Gain (Loss) | -26.93 | -8.83 | -0.33 | -0.07 | - | - |
Other Non Operating Income (Expenses) | -8.1 | -0.56 | -26.27 | -25.77 | -0.29 | 0.05 |
EBT Excluding Unusual Items | -323.29 | -310.68 | -232.83 | -190.76 | -119.68 | -74.08 |
Merger & Restructuring Charges | - | - | - | -5.53 | - | - |
Gain (Loss) on Sale of Investments | 0.1 | 1.12 | 30.12 | -162.54 | -382.65 | -623.76 |
Gain (Loss) on Sale of Assets | 0.09 | -0.06 | 0 | -0.06 | -0.13 | 0.01 |
Other Unusual Items | -2.5 | -6.64 | 4.15 | -0.22 | - | - |
Pretax Income | -325.6 | -316.26 | -198.56 | -359.12 | -502.46 | -697.84 |
Income Tax Expense | -1.54 | 0.1 | 0.05 | - | - | - |
Earnings From Continuing Operations | -324.06 | -316.36 | -198.61 | -359.12 | -502.46 | -697.84 |
Minority Interest in Earnings | 1.56 | 1.5 | 0.33 | 0.03 | 0.01 | 0 |
Net Income | -322.5 | -314.86 | -198.28 | -359.08 | -502.45 | -697.84 |
Net Income to Common | -322.5 | -314.86 | -198.28 | -359.08 | -502.45 | -697.84 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 1,231 | 1,176 | 904 | 584 | 281 | 150 |
Shares Outstanding (Diluted) | 1,231 | 1,176 | 1,000 | 584 | 281 | 150 |
Shares Change | 18.64% | 17.58% | 71.29% | 108.01% | 86.78% | - |
EPS (Basic) | -0.26 | -0.27 | -0.22 | -0.62 | -1.79 | -4.64 |
EPS (Diluted) | -0.26 | -0.27 | -0.23 | -0.62 | -1.79 | -4.64 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -230.63 | -192.34 | -163.37 | -152.84 | -117.08 | -60.01 |
Free Cash Flow Per Share | -0.19 | -0.16 | -0.16 | -0.26 | -0.42 | -0.40 |
Gross Margin | 43.03% | 40.65% | 44.16% | 47.71% | 29.20% | 56.72% |
Operating Margin | -117.14% | -132.22% | -151.12% | -218.43% | -921.71% | -3004.09% |
Profit Margin | -134.44% | -143.09% | -162.11% | -534.35% | -4450.02% | -30353.94% |
Free Cash Flow Margin | -96.14% | -87.41% | -133.57% | -227.44% | -1036.94% | -2610.05% |
EBITDA | -268.37 | -276.68 | -167.29 | -132.78 | -98.34 | -68.45 |
EBITDA Margin | -111.87% | -125.74% | -136.77% | -197.59% | - | - |
D&A For EBITDA | 12.64 | 14.27 | 17.55 | 14.01 | 5.73 | 0.61 |
EBIT | -281.01 | -290.95 | -184.83 | -146.78 | -104.07 | -69.06 |
EBIT Margin | -117.14% | -132.22% | -151.12% | -218.43% | - | - |